Correlation Between Scpharmaceuticals and Dominari Holdings

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and Dominari Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and Dominari Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and Dominari Holdings, you can compare the effects of market volatilities on Scpharmaceuticals and Dominari Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of Dominari Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and Dominari Holdings.

Diversification Opportunities for Scpharmaceuticals and Dominari Holdings

0.3
  Correlation Coefficient

Weak diversification

The 3 months correlation between Scpharmaceuticals and Dominari is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and Dominari Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dominari Holdings and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with Dominari Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dominari Holdings has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and Dominari Holdings go up and down completely randomly.

Pair Corralation between Scpharmaceuticals and Dominari Holdings

Given the investment horizon of 90 days Scpharmaceuticals is expected to under-perform the Dominari Holdings. In addition to that, Scpharmaceuticals is 1.52 times more volatile than Dominari Holdings. It trades about -0.19 of its total potential returns per unit of risk. Dominari Holdings is currently generating about -0.17 per unit of volatility. If you would invest  182.00  in Dominari Holdings on August 25, 2024 and sell it today you would lose (21.00) from holding Dominari Holdings or give up 11.54% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Scpharmaceuticals  vs.  Dominari Holdings

 Performance 
       Timeline  
Scpharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Scpharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Dominari Holdings 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Dominari Holdings are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating primary indicators, Dominari Holdings may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Scpharmaceuticals and Dominari Holdings Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Scpharmaceuticals and Dominari Holdings

The main advantage of trading using opposite Scpharmaceuticals and Dominari Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, Dominari Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dominari Holdings will offset losses from the drop in Dominari Holdings' long position.
The idea behind Scpharmaceuticals and Dominari Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges